SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-20-004836
Filing Date
2020-04-09
Accepted
2020-04-09 14:42:58
Documents
1
Period of Report
2020-04-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158645775951286.html 4  
1 FORM 4 wf-form4_158645775951286.xml 4 3974
  Complete submission text file 0001628280-20-004836.txt   5434
Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030
Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1212 TERRA BELLA AVENUE MOUNTAIN VIEW CA 94043
Business Address
Mokari Atabak (Reporting) CIK: 0001678419 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 20784061